Trump Taps His Own Criminal Defense Attorney For Lifetime Federal Judgeship
WASHINGTON — In a pathetic act of cowardice last year, a handful of Democrats tanked one of President Joe Biden's judicial nominees, Adeel Mangi.
Mangi, who was a veteran civil litigator in New Jersey, was an objectively impressive and qualified pick. He also happened to be Muslim, so Republicans subjected him to adisgustingmonthslongsmearcampaign aimed at baselessly casting him as an antisemitic terrorist sympathizer.
Despite his horrific treatment, Mangi hung in there, racking up endorsements from major Jewish organizations, and could have been confirmed if Democrats stuck together. But wary of their own reelection bids, a handful of senators chickened out and said they'd vote no. Then-Senate Majority Leader Chuck Schumer (D-N.Y.) sealed his fate by cutting a deal with Republicans to expedite votes on a batch of judicial nominees — but not Mangi.
President Donald Trump announced Wednesday whom he plans to nominate to this seat on the U.S. Court of Appeals for the 3rd Circuit: his personal criminal defense attorney, Emil Bove, who is currently known as Trump's hatchet manat the Justice Department.
'Emil is SMART, TOUGH, and respected by everyone,' Trump said on social media. 'He will end the Weaponization of Justice, restore the Rule of Law, and do anything else that is necessary to, MAKE AMERICA GREAT AGAIN. Emil Bove will never let you down!'
Bove, 44, was a federal prosecutor in the Southern District of New York before leaving for a private law firm in New Jersey. Todd Blanche, who is Trump's deputy U.S. attorney general, recruited Bove to help him defend Trump in his 2024 criminal indictment trial. Bove now serves as principal associate deputy attorney general under Blanche.
In his short time at the Justice Department, Bove has been abusing his role to punish people whom Trump considers his political enemies or to push out people who could stand in the way of Trump doing whatever he wants, laws be damned.
Among other things, Bove forced the transfer of top career officials who were seen as a firewall against political inference at the department, which otherwise operates independently from presidential administrations in enforcing laws.
He ordered the firings of federal prosecutors involved in the cases against more than 1,500 people charged in the Jan. 6, 2021, insurrection at the U.S. Capitol.
Bove also demanded the FBI turn over the names of its agents assigned to Jan. 6 cases, which led to a lawsuit and attorneys for the FBI agents saying they couldn't trust that the Justice Department wouldn't give their names to Trump purely so he could retaliate against them.
Carl Tobias, a law professor at the University of Richmond and a federal judicial nominations expert, said Bove's actions at the Justice Department alone 'should disqualify him for life tenure on the federal bench.'
Tobias also brought up Bove's role in the Justice Department's effort to drop corruption charges against New York City Mayor Eric Adams.
Adams was indicted on federal charges of bribery, fraud and soliciting illegal foreign campaign donations, but Bove pressured federal prosecutors to drop all charges in what appeared to be a brazen quid pro quo, with the administration dropping the case in exchange for Adams cooperating with Trump's immigration policies.
Several career attorneys resigned from the Justice Department rather than comply with Bove's demands, including Danielle Sassoon, the top federal prosecutor in Manhattan, who wrote in her resignation letter that it was her constitutional duty to 'prosecute crimes without fear or favor.' The case was ultimately dismissed.
'Bove's DOJ efforts show that he is a Trump loyalist and lacks the qualifications, especially wisdom and temperament, to serve as a federal judge,' said Tobias.
Sen. Cory Booker (D-N.J.), who recommended Mangi to Biden for this seat in 2023 and unsuccessfully fought for his confirmation, called Bove's nomination 'deeply troubling.'
'It is vital that the federal judiciary in New Jersey be committed to upholding the ideals of independence and objectivity,' Booker said in a joint statement with Sen. Andy Kim (D-N.J.). 'On this measure, Emil Bove has fallen short, repeatedly engaging in conduct as a top advisor in Trump's administration that undermines his credibility as an objective jurist.'
Progressive judicial advocacy groups have denounced Bove's nomination and urged senators to oppose his confirmation to the 3rd circuit court, which has jurisdiction in New Jersey, Delaware and Pennsylvania.
'Let's speak plainly: Emil Bove is being nominated to a circuit court seat because of his proven loyalty to Trump,' Maggie Jo Buchanan, interim executive director of Demand Justice, said in a statement.
'Bove has demonstrated time and time again his willingness to use his position to advance even the most dangerous and extreme actions of this administration,' she said. 'Any member of that chamber that purports to respect our system of governance must reject this nominee as antithetical to the foundational values of our nation and our courts.'
Caroline Ciccone, the president of Accountable.US, a progressive watchdog group focused on corruption in government, said 'every American should be alarmed' by Bove's nomination.
'Bove has consistently placed his loyalty to Trump over the Constitution,' Ciccone said in a statement. 'And his lifetime appointment would all but guarantee Trump and his allies could seek out favorable rulings regardless of how unconstitutional their actions are.'
Trump's first batch of judicial nominees is getting a hearing next Wednesday in the Senate Judiciary Committee, but Bove's nomination hearing hasn't been announced yet.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
People Truly Can't Believe The Location This Republican Senator Chose To Film Her "Apology"
I'm sure you've heard of Iowa Senator Joni Ernst's "we all are going to die" thing. She held a townhall on Thursday, and a clip of her comments about SNAP and Medicaid cuts went viral: At her town hall, when the crowd says people will die due to Medicaid and SNAP cuts, Joni Ernst responds "well we all are going to die." #iasen — danny (@dabbs346) May 30, 2025 ABC/dabbs346/Twitter: @dabbs346 Someone from the crowd shouted, "People are going to die," and Joni responded, "Well, we all are going to die." FWIW, The Hill reported she went on to say that Republicans would protect Medicaid for "the most vulnerable." She also said, "SNAP overpayments that the states have been making will need to stop," and "When you are arguing about illegals that are receiving Medicaid benefits, 1.4 million, they're not eligible, so they will be coming off." ANYWAY, this whole thing kind of blew up. People are calling this "one of the worst politician quotes" they've ever heard. And people are joking: "New GOP slogan: 'We're all gonna die!'" Related: 18 Major Global Events That American Media Is Ignoring Right Now, And Why They Actually Matter To Us Sooo, we're on round two from that. Senator Ernst decided to issue an "apology" that isn't really an apology at all. Against all odds, Joni Ernst has made it worse — Keith Edwards (@keithedwards) May 31, 2025 joniernst/Twitter: @keithedwards "Hello everyone, I would like to take this opportunity to sincerely apologize for a statement that I made yesterday at my town hall," she said. "See, I was in the process of answering a question that was asked by an audience member when a woman who was extremely distraught screamed out from the back of the auditorium, 'People are going to die.' And I made an incorrect assumption that everyone in the auditorium understood that, yes, we are all going to perish from this earth." "So, I apologize, and I'm really, really glad that I did not have to bring up the subject of the tooth fairy as well. But for those that would like to see eternal and everlasting life, I encourage you to embrace my Lord and savior Jesus Christ." Related: "I Am So Torn With What You Are Doing" — 11 Posts From MAGA Business Owners Who Are So Close To Getting It Yeaaah, people are unpacking this one. "I'm at a loss for words..." one person said. Another person encouraged her to keep digging in, "Keep posting through it Joni you're almost there." And this person joked, "Leave the tooth fairy out of this, you monster." But the #1 thing people can't believe is the location where she recorded it. It appears that she's walking through a cemetery. "I'm sorry... is she walking through a cemetery as she makes this?" one person asked. Another person said, "No way that Joni Ernst apology video can be real is she in a cemetery." And this person gave her a new nickname: "Senator Grim Reaper." Thoughts? Also in In the News: People Can't Believe This "Disgusting" Donald Trump Jr. Post About Joe Biden's Cancer Diagnosis Is Real Also in In the News: Miss USA's 2024 "National Costume" Has Been Revealed, And It's Obviously An Interesting Choice Also in In the News: One Body Language Expert Spotted Something Very Telling When Donald Trump "Held His Own Hand" At His Recent Press Conference

Epoch Times
31 minutes ago
- Epoch Times
Walz to South Carolina Democrats: ‘We Lost Our Way' as a Party
Former vice presidential candidate and Minnesota governor Tim Walz told Democratic Party voters in South Carolina on May 31 that their party had lost its way and needed to revive its identity as Democrats prepare to challenge for control of Congress and governorships in 2026. Walz, who was former Vice President Kamala Harris's running mate in 2024, gave the keynote address at the South Carolina Democratic Party Convention and opened with a general critique of President Donald Trump's second administration, mentioning topics including the One Big Beautiful Bill Act, the Department of Government Efficiency, tax policies, and the president's decision to accept Qatar's gift of a Boeing 747.
Yahoo
35 minutes ago
- Yahoo
Do Merit Medical Systems' (NASDAQ:MMSI) Earnings Warrant Your Attention?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. Sometimes these stories can cloud the minds of investors, leading them to invest with their emotions rather than on the merit of good company fundamentals. Loss making companies can act like a sponge for capital - so investors should be cautious that they're not throwing good money after bad. Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like Merit Medical Systems (NASDAQ:MMSI). While profit isn't the sole metric that should be considered when investing, it's worth recognising businesses that can consistently produce it. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. If a company can keep growing earnings per share (EPS) long enough, its share price should eventually follow. So it makes sense that experienced investors pay close attention to company EPS when undertaking investment research. It certainly is nice to see that Merit Medical Systems has managed to grow EPS by 34% per year over three years. As a general rule, we'd say that if a company can keep up that sort of growth, shareholders will be beaming. Careful consideration of revenue growth and earnings before interest and taxation (EBIT) margins can help inform a view on the sustainability of the recent profit growth. Merit Medical Systems maintained stable EBIT margins over the last year, all while growing revenue 8.2% to US$1.4b. That's a real positive. In the chart below, you can see how the company has grown earnings and revenue, over time. Click on the chart to see the exact numbers. View our latest analysis for Merit Medical Systems The trick, as an investor, is to find companies that are going to perform well in the future, not just in the past. While crystal balls don't exist, you can check our visualization of consensus analyst forecasts for Merit Medical Systems' future EPS 100% free. We would not expect to see insiders owning a large percentage of a US$5.6b company like Merit Medical Systems. But we do take comfort from the fact that they are investors in the company. Notably, they have an enviable stake in the company, worth US$132m. Holders should find this level of insider commitment quite encouraging, since it would ensure that the leaders of the company would also experience their success, or failure, with the stock. If you believe that share price follows earnings per share you should definitely be delving further into Merit Medical Systems' strong EPS growth. With EPS growth rates like that, it's hardly surprising to see company higher-ups place confidence in the company through continuing to hold a significant investment. On the balance of its merits, solid EPS growth and company insiders who are aligned with the shareholders would indicate a business that is worthy of further research. However, before you get too excited we've discovered 1 warning sign for Merit Medical Systems that you should be aware of. There's always the possibility of doing well buying stocks that are not growing earnings and do not have insiders buying shares. But for those who consider these important metrics, we encourage you to check out companies that do have those features. You can access a tailored list of companies which have demonstrated growth backed by significant insider holdings. Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data